跳至主要内容
临床试验/JPRN-UMIN000033297
JPRN-UMIN000033297已完成3 期

Efficacy of microwave ablation (MWA) vs. radio frequency ablation (RFA) on primary hepatocellular carcinoma: a randomized controlled trial - RCT on MWA and RFA for Patients with HCCs

Tokyo Medical University0 个研究点目标入组 240 人开始时间: 2018年7月6日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who have active double cancer (synchronous double cancer) or who have metachronous double cancer within five years disease duration: note that carcinoma in situ which is judged to be cure is not included 2.Patients who have diagnosed as myocardial infarction, unstable angina, cardiac failure, and arrhythmia with care within 6 months before registration 3.Patients who have either interstitial pneumonia, pulmonary fibrosis, and emphysema which is thought to be difficult to undergo this trial 4.Patients who have iodine allergies, decline in renal function (serum creatinine>1.5 mg/dL), and cannot undertake contrast-enhanced CT or MRI for any reasons 5.Patients who are judged to be difficult to undergo this clinical trial due to psychiatric disease or psychological symptom 6.Patients who are in pregnancy or probable of pregnancy 7.Besides, patients who are judged as inappropriate for registration by doctor in charge

研究者

相似试验